美国上市药品(最近批准)
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| BRYTLY (APRACLONIDINE) | BRYTLY | NDA220341 | — | — | — | ALCON LABORATORIES, INC. | — | 2026-10-16 | 2026-10-16 |
| BRYTLY (APRACLONIDINE) | BRYTLY | NDA220341 | 001 | SOLUTION/ DROPS | 0.125% | ALCON LABORATORIES, INC. | Prescription | 2026-10-16 | 2026-10-16 |
| AMPHOTERICIN B | AMPHOTERICIN B | ANDA220139 | — | — | — | QILU PHARM HAINAN | — | 2026-10-14 | 2026-10-14 |
| AMPHOTERICIN B | AMPHOTERICIN B | ANDA220139 | 001 | INJECTABLE, LIPOSOMAL;INJECTION | 50MG/VIAL | QILU PHARM HAINAN | Prescription | 2026-10-14 | 2026-10-14 |
| DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | ANDA208359 | 001 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;14MG | STRIDES PHARMA INTL | Prescription | 2026-10-13 | 2026-10-13 |
| DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | ANDA208359 | 002 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;28MG | STRIDES PHARMA INTL | Prescription | 2026-10-13 | 2026-10-13 |
| PRITELIVIR | HOVILPR | NDA221154 | 001 | TABLET; ORAL | 100MG | AICURIS ANTI-INFECTIVE CURES AG | Prescription | 2026-10-09 | 2026-10-09 |
| IOPAMIDOL | ISOVUE READI | NDA220583 | 001 | SOLUTION; ORAL | 200MG | BRACCO | Prescription | 2026-10-09 | 2026-10-09 |
| IOPAMIDOL | ISOVUE READI | NDA220583 | 002 | SOLUTION; ORAL | 250MG | BRACCO | Prescription | 2026-10-09 | 2026-10-09 |
| IOPAMIDOL | ISOVUE READI | NDA220583 | 003 | SOLUTION; ORAL | 300MG | BRACCO | Prescription | 2026-10-09 | 2026-10-09 |
上一页 第 1 / 3 页 下一页